This site is intended for Healthcare professionals only.

Granules’ arm completes audit with USFDA

Granules’ arm completes audit with USFDA

New Delhi: Pharma firm Granules India said its US subsidiary has received an observation from the USFDA on completion of the inspection.

“Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Chantilly, Virginia, US completed its first audit from December 4-8, 2017 by the USFDA (US Food and Drug Administration) with one observation,” the company said in a BSE filing.

The company, however, did not elaborate on the nature of the observation.

“Granules Pharmaceuticals Inc will respond to this observation within the stipulated time period,” it added.

Source: PTI
0 comment(s) on Granules’ arm completes audit with USFDA

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted